Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5356 to 5370 of 8314 results

  1. Further research should focus on the extended use of telemetric adjustable pulmonary artery banding for ventricular retraining and for its use pending the resolution of ventricular septal defects. Data collection may provide useful information. NICE may review the procedure on publication of further evidence.

    Recommendation ID IPG505/1 Question Further research should focus on the extended use of telemetric adjustable pulmonary artery banding

    Research recommendation
    Published
    9 June 2015

  2. Further research should include clear documentation of patient selection and of all complications. Outcomes should include pregnancy rates, live birth rates and instances of preterm delivery. Comparative studies would be helpful. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG509/1 Question Further research should include clear documentation of patient selection and of all complications.

    Research recommendation
    Published
    9 June 2015

  3. Further research should include details of patient selection and report longer term outcomes.

    Recommendation ID IPG777 Question Further research should include details of patient selection and report longer term outcomes. Any

    Research recommendation
    Published
    11 January 2024

  4. Further research should report:

    Recommendation ID IPG773 Question Further research should report: Any explanatory notes(if applicable) details of patient

    Research recommendation
    Published
    11 January 2024

  5. Further research should report details of patient selection, duration of the effect (including whether repeat procedures are needed), and long term outcomes.

    Recommendation ID IPG771 Question Further research should report details of patient selection, duration of the effect (including whether

    Research recommendation
    Published
    11 January 2024

  6. Further research should report details of patient selection, nodule size and position, and whether the nodule is cystic.

    Recommendation ID IPG643/1 Question Further research should report details of patient selection, nodule size and position, and whether

    Research recommendation
    Published
    19 March 2019

  7. Further research into the comparative efficacy and safety of different surgical and ablative treatments would be useful.

    Recommendation ID IPG405/1 Question Further research into the comparative efficacy and safety of different surgical and ablative treatments

    Research recommendation
    Published
    9 June 2015

  8. In its evaluation of burosumab, the committee noted substantial uncertainty in several areas, and agreed that further research into the treatment benefit of burosumab in young people aged 13 years and over would relieve some of the clinical uncertainty in an age group covered by the marketing authorisation.

    Recommendation ID HST8/1 Question In its evaluation of burosumab, the committee noted substantial uncertainty in several areas, and agreed

    Research recommendation
    Published
    22 March 2019

  9. Further research into whether concomitant dacarbazine enhances the clinical effectiveness of ipilimumab would be encouraged because it could provide information for future treatment strategies, as would more data on the relative effectiveness of ipilimumab when given as a first-line or second-line treatment.

    Recommendation ID TA319/2 Question Further research into whether concomitant dacarbazine enhances the clinical effectiveness of ipilimumab

    Research recommendation
    Published
    9 June 2015

  10. Further research into whether ticagrelor is particularly beneficial in any clinical or biological subgroups would be useful.

    Recommendation ID TA236/2 Question Further research into whether ticagrelor is particularly beneficial in any clinical or biological subgroups

    Research recommendation
    Published
    9 June 2015

  11. Further research is needed on the benefits and consequences of detecting preclinical diabetic peripheral neuropathy.

    Recommendation ID MTG38/1 Question Further research is needed on the benefits and consequences of detecting preclinical diabetic peripheral

    Research recommendation
    Published
    3 January 2019

  12. Further research is needed on the impact of faecal calprotectin testing on clinical decision-making when added to current practice. This includes research into optimal cut-off values for tests and the investigation of repeat testing strategies in people with intermediate levels of faecal calprotectin. Development of a consistent definition for the 'intermediate range' is encouraged.

    Recommendation ID DG11/2 Question Further research is needed on the impact of faecal calprotectin testing on clinical decision-making when

    Research recommendation
    Published
    9 June 2015

  13. Further research is needed on the use and clinical utility of faecal calprotectin testing, and support pathways for the long-term management of these conditions in the community should be developed.

    Recommendation ID DG11/1 Question Further research is needed on the use and clinical utility of faecal calprotectin testing, and support

    Research recommendation
    Published
    9 June 2015

  14. Further research is needed to understand the effect of having the additional information provided by the adjunctive colposcopy technologies on anxiety for people having a colposcopy, when this information is shown to a person during the examination.

    Recommendation ID DG32/3 Question Further research is needed to understand the effect of having the additional information provided by

    Research recommendation
    Published
    21 November 2018

  15. Further data collection and research are recommended to assess clinical outcomes after positive and negative SeHCAT test results. This research should focus on clinical outcomes relevant to people with chronic diarrhoea, such as severity of symptoms, including urgency. Clinical outcomes should be measured in the short and long term.

    Recommendation ID DG44/02 Question Further data collection and research are recommended to assess clinical outcomes after positive and

    Research recommendation
    Published
    16 December 2021